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a b s t r a c t
Mesenchymal dysplasia (mes) mice harbour a truncation in the C-terminal region of the Hh-ligand
receptor, Patched-1 (mPtch1). While the mes variant of mPtch1 binds to Hh-ligands with an afﬁnity
similar to that of wild type mPtch1 and appears to normally regulate canonical Hh-signalling via
smoothened, the mes mutation causes, among other non-lethal defects, a block to mammary ductal
elongation at puberty. We demonstrated previously Hh-signalling induces the activation of Erk1/2 and
c-src independently of its control of smo activity. Furthermore, mammary epithelial cell-directed
expression of an activated allele of c-src rescued the block to ductal elongation in mes mice, albeit with
delayed kinetics. Given that this rescue was accompanied by an induction in estrogen receptor-alpha
(ERα) expression and that complex regulatory interactions between ERα and c-src are required for
normal mammary gland development, it was hypothesized that expression of ERα would also overcome
the block to mammary ductal elongation at puberty in the mes mouse. We demonstrate here that
conditional expression of ERα in luminal mammary epithelial cells on the mes background facilitates
ductal morphogenesis with kinetics similar to that of the MMTV-c-srcAct mice. We demonstrate further
that Erk1/2 is activated in primary mammary epithelial cells by Shh-ligand and that this activation is
blocked by the inhibitor of c-src, PP2, is partially blocked by the ERα inhibitor, ICI 182780 but is not
blocked by the smo-inhibitor, SANT-1. These data reveal an apparent Hh-signalling cascade operating
through c-src and ERα that is required for mammary gland morphogenesis at puberty.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Estrogens are a class of hormones that play crucial roles in
diverse aspects of human biology, including sexual development
and reproduction. Dysregulation of estrogen signalling has been
implicated in a variety of diseases, including breast and uterine
cancers, osteoporosis and cardiovascular disease. Estrogen receptor-
alpha (ERα) is one of the principal protein receptors responsible
for mediating the actions of estrogen (Heldring et al., 2007). As a
member of the large superfamily of nuclear hormone receptors, ERα
acts as a ligand-activated transcription factor (Heldring et al., 2007;
Mangelsdorf et al., 1995). Upon binding of its ligand, 17β-estradiol
(E2), ERα modulates transcription by either binding directly to
estrogen response elements (ERE) in the promoter of E2 regulated
genes, or indirectly through protein–protein interactions with other
transcription factors (Heldring et al., 2007; Klinge, 2000).
ERα regulates target gene transcription through two indepen-
dent activation functions (AF), AF-1 and AF-2 (Arao et al., 2011;
Arnal et al., 2013; Lannigan, 2003; McGlynn et al., 2013). Tran-
scriptional activation by ERα can be promoted through functional
cooperation between the two AFs or through either AF indepen-
dently (Arnal et al., 2013). AF-2 contains the ligand binding
domain (LBD), and its activity depends on E2 binding (Arao
et al., 2011; McGlynn et al., 2013). Ligand-independent activation
is facilitated by the AF-1 domain. This domain harbours several
sequences that facilitate phosphorylation by factors mediating a
number of signal transduction pathways. For example, MAPK and
Cdk7 activates ERα by directly phosphorylating Ser118 within the
AF-1 domain (Bunone et al., 1996; Chen et al., 2002).
More recently, it was determined that E2 elicits changes in
cellular processes through ERα outside of the nucleus via activa-
tion of protein kinases, phosphatases and secondary messengers
(Haynes et al., 2003; Kousteni et al., 2001). One of these rapid
“non-genomic” signal transduction mechanisms includes the c-src
protein tyrosine kinase (Castoria et al., 2012; Li et al., 2007). ERα
transiently activates c-src in response to E2 binding by increasing
phosphorylation of Tyr416, resulting in downstream activation of
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ras and MAPK (Migliaccio et al., 1998, 1996). The SH2-domain of
c-src also interacts directly with ERα at Tyr537 (Arnold et al., 1995;
Migliaccio et al., 2000; Sun et al., 2012). Phosphorylation of Tyr537
by c-src rapidly activates signal transduction pathways involving
Erk and phosphoinositide 3-kinase (PI3K) (Varricchio et al., 2007),
as well as stimulating ERα target gene transcription, ERα ubiqui-
tylation and proteosomal degradation (Sun et al., 2012).
Genetic deletion of ERα in mice established important roles for
this receptor for normal adult mammary gland development.
Mammary glands of adult female ERα knock-out (αERKO) mice
fail to respond to ovarian hormones resulting in a failure of ductal
rudiments to elongate and ﬁll the fat pad (Couse et al., 2000;
Lubahn et al., 1993; Pedram et al., 2009). Interestingly, animals
lacking detectable c-src also exhibit defects in mammary gland
morphogenesis and primary mammary epithelial cells (MECs)
derived from c-src-null mice fail to respond to exogenous estrogen
stimulation (Kim et al., 2005). Thus, proper mammary gland
morphogenesis not only requires E2-activated ERα, but also
depends on ERα interaction with other signalling cascades.
We and others demonstrated previously that Hedgehog (Hh)-
signalling also plays a role in mammary gland development (Chang
et al., 2012; Moraes et al., 2009). Animals homozygous for the
mesenchymal dysplasia (mes) (Makino et al., 2001; Sweet et al.,
1996) allele of the Hh-ligand receptor, Patched-1 (Ptch1), displayed
a blocked mammary gland phenotype resembling that of the ERα
knock-out mice. The lack of ductal outgrowth in mes mice was
associated with reduced expression of ERα and progesterone
receptor (PR) in epithelial cells (Chang et al., 2012; Moraes et al.,
2009). The mes allele encodes a deletion in the second-last exon of
mPtch1, resulting in a truncated protein that replaces the last 220 a.
a. with a random 68 a.a. polypeptide. We showed that this region of
Ptch1 binds to factors containing SH3- and WW-domains, that the
SH3-domain of c-src binds to the C-terminus of mPtch1 (Chang
et al., 2010) and that transiently expressed mPtch1 binds to endo-
genous c-src in the absence of added Shh-ligand (Harvey et al., 2014).
Using a genetic approach, we showed further that forced expression
of an activated c-src (c-srcAct) transgene in luminal mammary
epithelial cells rescued the blocked mammary morphogenesis arising
in mes mice (Chang et al., 2012). This rescue was accompanied by a
strong increase in ERα expression.
Interactions between the ERα activity and Hh-signalling has also
been demonstrated. In ERα-positive gastric cancer cells, E2 induced
Shh expression and promoted cellular proliferation independent of
smo-activity (Kameda et al., 2010). A similar result was reported in the
ERα-positive breast cancer cell line, MCF-7. Here, E2 induced expres-
sion of Shh and Gli1. This activation is inhibited in cells treated with
the anti-estrogen, ICI 182780 (Koga et al., 2008). Inhibiting smo-
activity with the small molecule inhibitor, cyclopamine, signiﬁcantly
suppressed proliferation of both ERα-positive and ERα-negative breast
cancer cell lines, MCF-7 and MDA-MB-231, respectively (Che et al.,
2013). Cyclopamine also signiﬁcantly decreased ERα expression in
MCF-7 cells. Since c-src binds to mPtch1 (Chang et al., 2010; Harvey
et al., 2014) and also activates ERα (Castoria et al., 2012; Sun et al.,
2012), we sought to determine whether ERα-activity acts genetically
downstream of Ptch1. We demonstrate here that conditional expres-
sion of ERα overcomes the block to ductal elongation inmesmicewith
kinetics similar to those for the rescue of the mes phenotype by the
MMTV-c-srcAct allele. Furthermore, we deﬁne a novel pathway
stimulated by Shh that activates Erk1/2 and requires the activity of
either ERα or c-src but not smo.
Materials and methods
Cell culture. HEK 293 cells (a gift of S. Girardin) were cultured in
DMEM with 10% FBS and 1% penicillin-streptomycin. Shh Light II
ﬁbroblasts (ATCC) were cultured in DMEM supplemented with
400 mg/ml G418 (Gibco) and 0.14 μg/ml Zeocin (Invitrogen).
Mice. Wild type C57Bl/6N mice (Charles River) or C57Bl/6N
mice heterozygous for the mesenchymal dysplasia (mes) allele of
Ptch1 (JacksonLabs) were crossed with CERM mice, which harbour
a ﬂag-tagged ERα transgene under the control of the tetO and the
“Tet-On” transgene under the control of the MMTV promoter
(Díaz-Cruz et al., 2011; Frech et al., 2008, 2005; Hruska et al., 2002;
Miermont et al., 2010) (P. A. Furth, Georgetown University).
Compound mice were then backcrossed onto C57Bl/6 (CharlesRi-
ver) for 44 generations. Transgene expression was induced by
constant administration (changed twice per week) of 2 mg/ml
doxycycline in sterile-ﬁltered drinking water containing
5% sucrose.
For genotyping, tail DNA was extracted and 2 μl DNA was
ampliﬁed in a 25 μl polymerase chain reaction using Taq DNA
Polymerase (Thermo Scientiﬁc). Forward (F) and reverse (R) primer
sequences were as follows:
Mes: F 50-TCCAAGTGTCGTCCGGTTTG-30 and R 50-GTGGCTTCCA-
CAATCACTTG-30 (Chang et al., 2012); FLAG-ERα: F 50-CGAGCTCGG-
TACCCGGGTCG-30 and R 50-GAACACAGTGGGCTTGCTGTTG-30
(Miermont et al., 2010); MMTV-rtTa: F 50-ATCCGCACCCTTGATGA
CTCCG-30 and R 50-GGCTATCAACCAACACACTGCCAC-30 (Miermont
et al., 2010). Reaction conditions for MMTV-rtTa and meswere 60 s
each for denaturation, annealing and extension for 32 cycles, while
for FLAG-ERα they were 60 s denaturation, 90 s annealing, and
120 s extension for 35 cycles. The annealing temperatures for
mes, FLAG-ERα and MMTV-rtTa were 53 1C, 57 1C and 56 1C,
respectively.
Whole mount analysis. Whole mount analysis of mammary
glands was performed as previously described (Chang et al.,
2012; Rasmussen et al., 2000). Brieﬂy, mammary glands were
ﬁxed in Carnoy's ﬁxative (10% acetic acid, 30% chloroform, 60%
ethanol) overnight at 4 1C, and washed in 70%, 50% and 25%
ethanol for 15 min each. The glands were rinsed in water for
5 min and then stained in Carmine alum overnight at room
temperature. The glands were washed in 70%, 95% and 100%
ethanol for 15 min each, and then cleared in xylene for two
changes for 30 min each followed by mounting with Permount.
Immunoﬂuorescence. Parafﬁn-embedded tissue sections were
deparafﬁnized in xylene and rehydrated gradually through 100%,
95%, 80%, 70% ethanol washed and water. Antigen retrieval was
performed by boiling sections for 15 min in 10 mM sodium citrate,
pH 6.0, in a pressure cooker pre-heated in a microwave oven for
20 min before immersing slides. After boiling, sections were
permeabilized with 0.2% TritonX-100 for 10 min. After washing,
sections were incubated with primary antibodies for 1 h at room
temperature in 3% BSA in PBS. Antibodies and dilutions are as
follows: 1:100 anti-ERα (Santa Cruz; sc-542), 1:100 anti-BrdU
(abcam: ab6326), 1:20 anti-Flag (abm;G191) and undiluted anti-
Alx4 containing supernatant (produced in our lab). Sections were
then washed and labelled with ﬂuorescently-labelled secondary
antibody added to samples for 1 h. Sections were imaged using a
Nikon Ellipse ﬂuorescent microscope equipped with a QImaging
Fast1394 digital camera and compiled using Qcapture Pro software
(QImaging).
Preparation of Shh-conditioned media. Shh-conditioned media
was prepared as previously described (Capurro et al., 2012). Shh-
and pcDNA-conditioned media were prepared by transfecting 40%
conﬂuent 10 cm plates of HEK293 cells in 10% FBS with 10 μg of
pcDNA3.1-N-Shh (gift of J. Filmus, Sunnybrook Health Sciences
Centre) or pcDNA3 using 2 mg/ml PEI at a 2:1 ratio. Cells were
grown for 24 h before the media was switched to 5% FBS for 48 h.
The media was collected, centrifuged at 2500 rpm for 5 min at 4 1C
and harvested. The supernatant was then sterile-ﬁltered using a
0.22 μm syringe ﬁlter. Prior to use, conditioned media was diluted
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in serum free DMEM to a ﬁnal serum concentration of 0.5%.
Activity of conditioned media was measured in a luciferase
assay in Shh Light II ﬁbroblasts (Chang et al., 2010; Sasaki et al.,
1997).
Primary cell culture. Primary mammary epithelial and mesench-
ymal cells were isolated as described previously (Chang et al.,
2012; Niranjan et al., 1995). Brieﬂy, thoracic and inguinal mam-
mary glands were dissected from euthanized mice and minced
with a razor blade into small fragments. The minced mammary
glands were incubated in a solution of 3 mg/ml collagenase A and
trypsin (Sigma-Aldrich) in DMEM/F12 for 2 h at 37 1C. Mechanical
dissociation was then performed by slowly pipetting with a 5 ml
pipette, adding FBS to a ﬁnal concentration of 2%. Epithelial
(pelleted) and mesenchymal (supernatant) layers were separated
by centrifuging at 200 rpm for 2 min. The mesenchymal layer was
collected and washed with DMEM/F12 and plated in DMEM/F12
containing 10% FBS supplemented with 10 μg/ml insulin, 10 μg/ml
transferrin and 20 ng/ml EGF. For organoid culture, the epithelial
pellet was resuspended in 3 mg/ml collagenase A in DMEM/F12
and incubated for 30 min at 37 1C. The cells were pelleted by
centrifugation, washed and plated in primary culture media
mentioned above. The organoid containing media was removed
and re-plated once the remaining mesenchymal cells attached to
the plate (2 h).
For Erk1/2 activation assays, primary mouse mammary epithe-
lial cells and mesenchymal cells were serum starved in 0.2% FBS
containing culturing media for 24 and 48 h, respectively. Cells
were then stimulated with pcDNA3-conditioned media, Shh-
conditioned media, or Shh-conditioned media with either 10 nM
ICI 182 780, 20 nM SANT-1 (Toronto Research Chemicals), or 10 nM
PP2 for 24 h. Cells were lysed in 1% NP40 lysis buffer and levels of
phospho-Erk1/2 and total Erk1/2 determined by western blot.
Western blotting. Cell lysates were prepared following addition
of 1% NP40 lysis buffer containing protease and phosphatase
inhibitors (0.57 mM PMSF, 10 μM leupeptin, 0.3 μM aprotinin,
10 mM NaF, 1 mM sodium orthovanadate). For western blots, 4
SDS-loading buffer (50 mM Tris pH 6.8, 100 mM DTT, 2% SDS, 0.1%
bromophenol blue, 10% glycerol) was added to 50 mg of lysate and
boiled for 5 min. Samples were resolved by 10% SDS-PAGE and
blotted onto nitrocellulose membrane. Blots were probed with
primary antibody overnight at 4 1C. Antibodies and dilutions used
are as follows: 1:1000 mouse α-p-ERK (Cell Signaling) and 1:1000
rabbit α-ERK (Cell Signaling). Blots to be re-probed were stripped
in stripping buffer (2% SDS, 62.5 mM Tris pH 6.8, 100 mM β-
mercaptoethanol) for 30 min at 72 1C.
Quantitative RT-PCR. For quantitative RT-PCR (qPCR), total RNA
was isolated from primary mouse mammary mesenchymal and
epithelial cells using Trizol (Invitrogen). DNAse treatment (Fer-
mentas) was performed on 400 ng of RNA from each sample.
Reverse transcription was performed using SuperScript II Reverse
Transcriptase (Invitrogen) and random hexamer primers (Fermen-
tas). Resulting cDNA was diluted 1:25 and qPCR was then per-
formed using an iQ SYBR Green Supermix (Bio-Rad) in 10 μl
reactions. All reactions consisted of 40 cycles with 30 s denatura-
tion at 72 1C, 30 s annealing and 30 s extension at 60 1C. Primer
speciﬁcity was conﬁrmed by a melt curve analysis. Results were
quantiﬁed using the ΔΔCt method with Arbp as a reference gene.
Primers adapted from previously published sequences (Webster








Mice homozygous for the mes allele exhibit a block to ductal
elongation in the mammary gland during puberty. This defect is
overcome, albeit with distinct kinetics relative to wild type
animals, by constitutive expression of activated c-src under the
control of the MMTV-promoter. Given the increased expression of
Fig. 1. Forced expression of ERα rescues the mammary gland phenotype in mes mice. Mammary gland #4 was isolated from twenty week-old mice and whole mounts
prepared. (A) and (A0) mes; (B) and (B0) mes/CERM. After twenty weeks, mammary ductal morphogenesis in mes mice is blocked. This phenotype is reversed in mes mice
expressing ERα directed to mammary epithelium, albeit with delayed kinetics. Magniﬁcation of ducts reveal a non-proliferative rudimental ductal structure inmesmammary
glands (A0). Terminal end buds are present and ductal structures have not reached the limits of the fat pads in mes/CERM mice (B0).
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ERα in mes/MMTV-c-srcAct mice and the role of c-src in activating
ERα, we hypothesized that forced expression of ERα would also
rescue the mes phenotype. CERM mice (Frech et al., 2005; Tilli
et al., 2003), a compound transgenic mouse that harbours a tetO-
ERαFlag allele under the control of MMTV-”Tet-On”, were bred to
mes mice and backcrossed onto a C57Bl/6 background. ERα
expression in compound mes/CERM mice was then induced by
long-term administration of the doxycycline beginning at 3 weeks
of age. As Fig. 1A and A0 illustrate, at 20 weeks of age, mammary
gland #4 in the adultmes females had not developed, remaining in
the state that developed during embryogenesis. However, as
Fig. 1B shows, ductal elongation was apparent in compound mice
homozygous for the mes allele and expressing MMTV-directed
ERα (mes/CERM). At this stage, terminal end buds were also
apparent (Fig. 1B0) indicative of these ducts elongating into the
fat pad similar to that observed for wild type mice at puberty.
Similar to the observation we reported previously for mes/
MMTV-c-srcAct mice (Chang et al., 2012), the rescue by CERM mice
of the mes phenotype exhibited distinct kinetics of ductal elonga-
tion relative to the development of wild type mammary glands
(Fig. 2). By ten weeks of age, only rudimentary ductal structures
resembling those of their mes littermates were seen for
doxycycline-fed mes/CERM mice (Fig. 2A). However, between 15
and 20 weeks, the mammary ducts in doxycycline-fed mes/CERM
mice had penetrated the fat pad to various degrees (Fig. 2B).
Signiﬁcantly, terminal end buds (TEBs) were present in these
animals (see Fig. 1B0). Complete morphogenesis was observed in
doxycyline-fed mes/CERM females between 24 to 30 weeks of age
(Fig. 2C). For these mature animals, the ducts in these mammary
glands reached the limits of the fat pad and TEBs were no longer
present. As we reported previously (Chang et al., 2012), develop-
ment of the mammary glands in mes littermates beyond the
primitive ductal structures established during embryogenesis
was not observed, even at thirty weeks (Fig. 2E) nor were ducts
evident in mes/CERM animals not induced with doxycycline
(Fig. 2F).
To determine if the mammary ducts of mes/CERM mice
exhibited normal epithelial organization, sections were probed
for ERα and the myoepithelial marker, p63 (Fig. 3). Nuclear ERα
expression was observed in mammary epithelial cells from ducts
of adult virgin wild type, mes, wild type/CERM and mes/CERM
mice. Expression of ERα was restricted to the luminal epithelial
cells, evident by the lack of overlap between signals for ERα with
p63. As we demonstrated previously (Chang et al., 2010; Moraes et
al., 2009), reduced ERα expression was observed in mes mice
(Fig. 3E and H) compared to wild type littermates (Fig. 3A–D).
While approximately 40% of epithelial cells were positive for ERα
staining in wild type animals, ERα staining was only observed in
10–20% of epithelial cells in mes littermates. An approximate 2-
fold increase in the percentage of cells demonsrating nuclear
localized ERα expression was observed in mes mice expressing
MMTV-ERα, relative to mes alone. However, expression levels and
subcellular localization of ERα were indistinguishable between
wild type (Fig. 3A–D), mes/CERM (Fig. 3M–P) and WT/CERM
(Fig. 3I and L) littermates.
Immunoﬂuorescence revealed that induction of the conditional
ERα expression in both wild type and mes mice caused aberrant
cell cycle progression in adult mammary glands (Fig. 4). Speciﬁ-
cally, cells incorporating BrdU were essentially absent in the
mammary glands of wild type adult animals (Fig. 4A and D).
Fig. 2. Delayed rescue of mammary morphogenesis in mes/CERM mice is complete by thirty weeks. Whole mounts of mammary gland #4 were prepared from glands
isolated from age-matched littermates at different points during development. (A) Mammary glands from mes/CERM exhibit no ductal proliferation at ten weeks, while wild
type littermates (D) are completely developed. (B) Terminal end buds with partial ﬁlling of the mammary gland fat pad by ductal elongation are found in mes/CERM females
at twenty weeks of age. (C) Ducts have reached the limits of the fat pad by thirty weeks of age and terminal end buds are no longer present. (F) Mammary glands from
uninduced adult mes/CERM mice fail to develop and resemble mammary glands from mes mice (E) that exhibit only a rudimentary ductal tree, even at thirty weeks. Rescue
of the mes mammary defect by ERα in animals older than eighteen weeks is signiﬁcant (p¼0.0278; Fisher's exact test). Ductal structures are magniﬁed in corresponding
inserts. Scale bar: 50 μm.
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However, following the 2 h pulse of BrdU, a fraction of cells in
every duct in doxycycline-fed WT/CERM (Fig. 3E and H) and mes/
CERM (Fig. 3M–P) mice stained positively, indicating the presence
of cycling cells due to the induced expression of ERα. BrdU
incorporation was not observed in WT/CERM mice not fed dox-
ycycline (Fig. 4I and L). Cells expressing detectable levels of the
ﬂag-tagged ERα transgene were not associated with the cells that
had incorporated BrdU (Supplementary Fig. 1), although all BrdU-
incorporating cells stained with an anti-ERα antibody (Fig. 4C and
D), suggesting that transgene expression generated an overall
proliferative state in the mammary gland rather than driving
speciﬁc cells through the cell cycle.
To further investigate the overall proliferative state of the
mammary gland, changes in the expression of the stromally-
restricted, homeodomain protein, Alx4 (Hudson et al., 1998; Qu
et al., 1998, 1997a, 1997b), were assessed. Alx4 is induced in
stromal ﬁbroblasts during puberty and pregnancy but is not
expressed in the resting adult mammary gland (Hudson et al.,
1998; Joshi et al., 2006). Furthermore, administration of E2 to pre-
pubescent female mice induces Alx4 expression in these ﬁbro-
blasts while the absence of Alx4 in stromal ﬁbroblasts in Strong's
luxoid mice causes defects in mammary ductal morphogenesis
during puberty. Thus, we examined the expression of Alx4
expression in stromal cells in wild type and mes adults that
conditionally expressed ERα (CERM mice) and compared these
to mammary glands expressing activated c-src under the control of
the MMTV promoter. As Fig. 5A and B illustrates, Alx4 expression
was generally absent in the adult wild type stromal cells adjacent
the epithelial ducts. However, in wild type mice with induced ERα
(Fig. 5E and F) or constitutive expression of c-srcAct (Fig. 5C and D)
in mammary epithelial cells, an induction of Alx4 expression in
stromal ﬁbroblasts in these adult animals was apparent. In con-
trast to CERM or MMTV-c-srcAct on the wild type background,
however, Alx4 expression was not induced by these two alleles on
the mes background (Fig. 5I, J and K,L, respectively). Thus, the
luminal epithelial-restricted expression of either ERα or c-srcAct
appeared to generate a signal, emanating from mammary epithe-
lial cells, that stimulated stromal ﬁbroblasts to express Alx4. The
induction of Alx4 expression in these ﬁbroblasts was dependent,
however, on the presence of wild type mPtch1.
E2 rapidly activates the MAPK signalling pathway in the human
breast cancer cell lines, MCF-7 and T47D (Castoria et al., 1999;
Improta-Brears et al., 1999; Migliaccio et al., 1996; Song et al., 2002),
in a c-src-dependent manner (Di Domenico et al., 1996; Song et al.,
2002). Shh-ligand also stimulates the activation of both Erk1/2
(Chang et al., 2010) and c-src (Harvey et al., 2014) in a human
mammary epithelial cell line, MCF10a, that lacks detectable expres-
sion of smo (Chang et al., 2012, 2010; Mukherjee et al., 2006; Zhang
et al., 2009). As Fig. 6A illustrates, phosphorylation of Erk1/2 was
induced in wild type, serum-starved primary mammary epithelial
cells within 15 min of stimulation by N-Shh. Stimulation occurred in
the presence of the smo-antagonist, SANT-1, which we showed
Fig. 3. mes/CERM ducts demonstrate normal cellular organization and ERα expression. Immunoﬂuorence staining for ERα and p63 in adult virgin wild type ((A)–(D)), mes/
mes ((E)–(H)), wild type/CERM ((I)–(L)) and mes/CERM ((M)–(P)) mice. No co-localization of ERα is observed with p63 ((D), (H), (L) and (P)). Reduced ERα expression is
apparent in mesmice (F) compared to wild type (p¼0.02) (B). ERα expression is increased, however, in mes mice expressing MMTV-ERα (p¼0.021) (N), but expression levels
do not differ between mes/CERM and wild type littermates. Scale bar: 25 mm. ERα-positive cell percentages were determined by cell counting; 10 ﬁelds per animal, n¼3 for
all animal groups. Data was analyzed by one-way ANOVA followed by pairwise comparisons of means using Dunnett's multiple comparison's test.
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Fig. 4. Forced ERα expression induces cell cycle progression in adult mammary glands. Twenty four week-old wild type ((A)–(D)), induced wild type/CERM ((E)–(H)),
uninduced wild type/CERM ((I)–(L)) and mes/CERM ((M)–(P)) littermates were injected with BrdU 2 h prior to mammary gland excision and incorporation was determined
through immunoﬂuorescence. BrdU incorporation was absent in the mammary glands of 24 week-old adult wild type mice (B). Cells positive for BrdU staining are observed
in ducts from both induced wild type/CERM (F) andmes/CERMmice (N), but not in wild type/CERM that were not fed doxycycline (J). BrdU positive cells co-localize with cells
expressing ERα ((H) and (P)). Scale bar: 25 mm.
Fig. 5. Conditional expression of ERα induces stromal expression of Alx4 in adult female mice. Mammary glands of wild type ((A)–(B)), wild type/c-srcAct ((C)–(D)), wild type/
CERM ((E)–(F)), mes ((G)–(H)), mes/c-srcAct ((I)–(J)), mes/CERM (induced) ((K)–(L)) virgin 24 week-old adult female mice were stained for Alx4. Staining is absent in wild type
mammary ducts. Expression of constitutive c-srcAct or conditional ERα in ductal epithelial cells induces stromal expression of Alx4. Scale bar: 25 mm.
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previously inhibited canonical Hh-signalling in primary mammary
mesenchymal cells (Harvey et al., 2014). Activation of Erk1/2
occurring through a smo-independent mechanism (Fig. 6E) is also
consistent with our previous observations using the smo-deﬁcient
MCF10a breast cancer line (Chang et al., 2010) as well as in smo-
deﬁcient MEFs (unpublished observation). Thus, the dependence of
c-src activity on N-Shh stimulation of Erk1/2 was determined in
primary mammary epithelial cells treated with the c-src inhibitor
PP2 (Hanke et al., 1996). As Fig. 6E shows further, a complete block
of Erk1/2 activation occurs when c-src activity is inhibited.
The role of ERα for N-Shh activation of Erk1/2 was then
determined by stimulating cells in the presence of the anti-
estrogen, ICI 182780 (Wakeling et al., 1991). As illustrated in
Fig. 6C, ICI 182780 partially inhibited Erk1/2 activation by N-Shh
ligand. Speciﬁcally, treatment of primary epithelial cells with N-
Shh-conditioned media caused a 4-fold increase in Erk1/2 phos-
phorylation. This level of activation was reduced by 50% in the
presence of ICI 182780. Thus, N-Shh activated Erk1/2 in the
presence of the smo-inhibitor, SANT-1, but required the activities
ERα and c-src.
While N-Shh stimulates non-canonical Hh-signalling cascades
in both primary mammary epithelial and mesenchymal cells, smo-
dependent canonical Hh-signalling in primary epithelial cells has
not been reported. Thus, primary epithelial and mesenchymal cells
from wild type mammary glands were stimulated with N-Shh
peptide and changes in expression of both Hh-pathway targets,
Gli1 and Ptch1 were determined. As Fig. 7A reveals, stimulation of
primary mammary mesenchymal cells resulted in a greater than
25-fold increase in Gli1 expression. Likewise, Fig. 7B illustrates the
4-fold increase in Ptch1 expression in these same cells. We
demonstrated previously that Gli1 and Ptch1 induction in primary
mouse mesenchymal cells through N-Shh stimulation was depen-
dent on the activity of smo, since induction is abolished in cells
treated with N-Shh in the presence of SANT-1 or by using heat-
killed N-Shh peptide (Harvey et al., 2014). However, despite the
apparent response of these mesenchymal cells to N-Shh ligand, a
very limited or no induction of Gli1 and Ptch1, respectively, were
observed for primary epithelial cells. Speciﬁcally, a small but
signiﬁcant 3-fold increase in Gli1 levels was observed after 24 h
while no induction of Ptch1 was observed. Thus, mammary
epithelial cells are relatively refractory to stimulation through
the canonical Hh-pathway but are able to respond through non-
canonical pathway, determined by the activation of Erk1/2 by
N-Shh.
Taken together, using both a genetic approach and experiments













































































































Fig. 6. Shh activates Erk1/2 in primary mammary epithelial cells is an ERα- and c-Src- dependent manner. Primary mammary epithelial cells isolated fromwild type mice at
three months of age were serum starved for 24 h and then treated with Shh-conditioned media, pcDNA3-control media, or Shh-conditioned media with ICI 182 780, SANT-1
or PP2 for 1 h. Blots were probed for activated (phospho)-Erk1/2 and then re-probed for total Erk1/2. (A) Activation of Erk1/2 is observed 15 min following stimulation by
sonic hedgehog. (C) Addition of ICI 182 780 1 h prior to Shh stimulation partially inhibits Erk1/2 activation. (E) Cells were treated with 20 nM SANT-1 or 5 μM PP2 for 1 h
before Shh stimulation. PP2, but not SANT-1 treatment inhibits Shh-dependent Erk1/2 activation. Quantiﬁcation of Erk1/2 activation are shown ((B), (D) and (F)). Data were
analyzed by two-way ANOVA followed by pairwise comparison of means using Dunnett's multiple comparisons test. Data are displayed as mean7SEM, n¼3 for all groups,
except PP2þShh, n¼2. *po0.05.
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novel Hh-signalling pathway involving the activities of ERα and
c-src is required for regulating mammary gland development.
Discussion
The Hedgehog-signalling pathway regulates morphogenesis in
a large number of tissues. Detailed genetic and molecular studies
have shown further that control of these processes by the Hedge-
hog ligands is typically mediated by control of the activities of the
Patched-1 receptor that, in turn, indirectly controls the activity of
smo. Interestingly, the primary sequence of mPtch1 predicts that,
while potentially habouring a sterol-sensing domain (Carstea
et al., 1997; Loftus et al., 1997), signalling cascades involving the
direct association of SH3 or WW-domains with Ptch1 may also be
involved in Hh-signalling. Our previous studies showed that a
number of factors harbouring these domains can associate with
the cytoplasmic C-terminal region of mPtch1 (Chang et al., 2010).
These include the SH3-domains of signalling factors such as c-src,
Grb2 and PIK3R2 (p85α) as well as factors harbouring WW-
domains such as the E3 ubiquitin ligases, WWP2 and Smurf2.
Supporting this was the recent observation that Drosophila Smurf
(dSmurf) complexes Drosophila Patched (dPtch) (Huang et al.,
2013).
Further evidence of Hh-pathways operating independently of
smo was revealed in the mesenchymal dysplasia (mes) mouse
(Sweet et al., 1996). The 32-bp deletion in this animal in the
sequence encoding the mPtch1 C-terminus causes a truncation in
this region of mPtch1 and the addition of a small amount of an
unrelated, random sequence (Makino et al., 2001). A number of
non-lethal defects arise in this mouse, including a block to
mammary gland morphogenesis during puberty. As we have
shown, this defect is not due to the lack of ovarian hormones
but rather to the apparent unresponsiveness in cells of the
mammary gland to these factors (Chang et al., 2012; Moraes
et al., 2009). Despite these defects, the mes variant of the mPtch1
protein binds Shh-ligand with an afﬁnity similar to the wild type
mPtch1 (Nieuwenhuis et al., 2007) and appears to facilitate
signalling through the canonical Hh-signalling pathway similar
to cells with the full length protein (Harvey et al., 2014). Thus, in
the context of the canonical Hh-pathway, the basis for blocked
morphogenesis in the mes mammary gland is not apparent.
We hypothesized and showed previously, however, that the
defect in the mes mammary gland could be rescued, albeit with
delayed kinetics, by expressing an activated version of c-src
(Chang et al., 2012). Among changes in the mammary glands of
the mes/MMTV-c-srcAct mice was a signiﬁcant increase in the
levels of expression of ERα relative to mes mice alone and its
accumulation in the cytoplasm of mammary epithelial cells. These
data suggested that Hh-signalling in the mammary gland may
require, at least in part, signalling through pathways that con-
trolled the expression and activities of ERα and that forced
expression of ERα in mes mice might also rescue the mes
mammary phenotype. As we demonstrated here, conditional
expression of an ERα transgene under the control of the MMTV
promoter also overcame the block to mammary morphogenesis
with kinetics similar to that of the MMTV-c-srcAct allele. Thus,
these two distinct mouse models have revealed a novel Hh-
signalling pathway, involving c-src and ERα, that plays an impor-
tant role in postnatal mammary gland morphogenesis.
We note that the phenotype of the mes mice we reported in
this and our previous paper (Chang et al., 2012) differs from a
previous report (Moraes et al., 2009). In the latter paper, the
blocked development of the mammary gland at puberty was not
as robust as we have observed. The reason for the differences
between these phenotypes is not apparent, particularly given that
both labs backcrossed their animals onto C57Bl/6 backgrounds,
albeit, using C57Bl/6 mice from colonies that ﬁrst diverged in 1951
(Charles River (C57Bl/6N) versus Jackson Labs (C57Bl/6J)). We have
characterized almost 40 mes mice on the C57Bl/6N background
and have found only 3 with partial ductal development of
mammary gland #4. Furthermore, for both the mes/MMTV-c-srcAct
andmes/CERM animals, ductal growth was not apparent until after
about 15 weeks, again supporting the stronger penetrance of mes
mammary phenotype in our colony. Similar to Moraes et al.,
however, we observed that mixing FVB onto the mes/C57Bl/6N
background had no effect on the mes phenotype (unpublished
observation).
Our data also showed that stimulation by N-Shh of primary
mammary epithelial cells activated Erk1/2 in both an ERα and c-src-
dependent manner. Inhibition of activation of either factor, but not
inhibition of smo, reduced or blocked the ability of N-Shh to
stimulate Erk1/2. Thus, the non-canonical Hh-signalling pathway
we identiﬁed previously appears to involve changes in the activities
of ERα and c-src in mammary epithelial cells. The precise mechan-
ism remains undeﬁned. It is clear, however, that the activities of
both c-src and ERα are required for the N-Shh-dependent activation
of Erk1/2. In the presence of inhibitors that blocked the activities of
ERα or c-src, respectively, N-Shh-dependent Erk1/2 activation was

























































































Fig. 7. Limited canonical Hh-signalling in primary mammary epithelial cells.
Primary mammary epithelial and mesenchymal cells isolated from three month-
old wild type mice were serum starved for 24 h and 48 h, respectively. Cells were
then stimulated with heat-killed N-Shh peptide, active N-Shh peptide, or N-Shh
peptide with 20 nM SANT-1 for 24 h. (A) qPCR reveals that Gli1 is induced 25-fold
in mesenchymal by N-Shh. Only a small but signiﬁcant 3-fold increase in Gli1 was
seen in epithelial cells from the same animals, however. (B) N-Shh peptide induced
Ptch1 expression 3.5-fold in mesenchymal cells. No induction of mPtch1 was
observed for epithelial cells. Data were annalyzed by one-way ANOVA followed by
pairwise comparisons of means by Dunnett's multiple comparisons test. Data are
displayed as mean7SE, *po0.05, n¼3.
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molecule inhibitor of smo, SANT-1, had no effect. Thus, these data
support the existence of a pathway stimulated by the Hh-ligands in
mammary epithelial cells that operates through both c-src and ERα
resulting in the activation of Erk1/2.
In both MMTV-c-srcAct and in CERM mice on the mes back-
ground, a signiﬁcant increase in the levels of ERα relative to mes
mice alone are observed in the mammary epithelial cells. The
altered expression of ERα suggested that the level of its expression
required for ductal morphogenesis at puberty in response to 17β-
estradiol requires the normal activity of the mPtch1 C-terminus.
This model does not preclude the possibility that the canonical
Hh-pathway, signalling through smo, is also required. This possi-
bility has not been strictly tested in the mouse mammary gland (i.e.
conditional or tissue-speciﬁc knock out of smo in mammary
epithelial and/or mesenchymal cells). However, mice harbouring
conditional c-srcAct or ERα alleles are sufﬁcient to overcome the
block to the pubescent mammary morphogenesis and is associated
with increased levels of ERα relative to mes mice alone.
Our data also revealed the mPtch1-dependent activation of the
mammary stromal cells in vivo. Speciﬁcally, Alx4-expression was
probed in mammary glands of wild type mice expressing mam-
mary epithelial-restricted ERα or c-srcAct. In adult mice taken at 24
weeks, the stromally-restricted paired-like homeodomain tran-
scription factor, Alx4, was induced in mammary ﬁbroblasts
whereas the wild type adults do not express Alx4 in these cells.
We conclude that ERα or c-src expression in the luminal cells
induced the expression of factors that stimulated the surrounding
stromal cells. Interestingly, despite the rescue by ERα and c-src in
the mes mice, induction of Alx4 expression was not observed in
mes stromal cells. Thus, wild type mPtch1 appears to be required
for stromal induction of Alx4 by adjacent mammary epithelial
cells. The basis for the difference between mes and wild type mice
has not been deﬁned. We propose the possibility that ERα and c-
src induce the expression of a Hh-ligand in mammary epithelial
cells. This ligand then stimulates adjacent mesenchymal cells to
express Alx4 but is dependent on the activities of wild type
mPtch1in these cells. This model can be tested in reciprocal
transplantation experiments between mes and wild type mam-
mary glands. Regardless, these data offer further evidence for the
role of components of the Hh-pathway in mediating signalling
interactions between stromal and epithelial compartments in the
developing mammary gland.
While the focus of this study was on Hh-signalling that
operates, at least in part, through novel non-canonical signalling
pathways, we also tested the response of primary mammary
epithelial cells in culture to signal through the smo-dependent
canonical pathway. Under the conditions of primary cell culture,
we observed that primary mammary epithelial did not induce
expression of the Hh-target gene, mPtch1, and only weakly
induced mGli1. In contrast, primary mesenchymal cells from the
same animals responded robustly to the same N-Shh ligand, as
evident by mPtch1 and mGli1 expression levels being strongly
induced. The lack of signalling in primary epithelial cells through
the canonical pathway is consistent with the lack of response we
observed for human cell lines derived from breast cancers or
untransformed cells, including MCF7, MDA-MB-231 and MCF10a
(Chang et al., 2010 and unpublished observations). For some of
these latter lines, speciﬁcally MCF10a and MDA-MB-231, the
expression of smo message appears to be absent, at least as
determined by sensitive rtPCR studies of smo expression in these
cells (Chang et al., 2010; Mukherjee et al., 2006; Zhang et al.,
2009). The failure to stimulate the canonical pathway by N-Shh is
distinct from the myriad of studies describing the consequences of
altered expression of the downstream Hh-pathway components
on cell growth, mobility, transformation or metastasis in mam-
mary epithelial cell lines or, more often, breast cancer cell lines
(for reviews, see Che et al., 2013; Cui et al., 2010; Hui et al., 2013;
O’Toole et al., 2009). However, these studies have typically not
described the activation of the canonical Hh-pathway upon
stimulation by Hh-ligand. Indeed, evidence suggests that the “Hh
repression state”, that is the state in which Gli3 acts as a repressor
(Gli3rep), is required for normal mammary gland development
(Hatsell and Cowin, 2006; Hui et al., 2013). It might be expected,
therefore, that changes to the expression of downstream factors
that overcome the dominance of the Gli3rep might lead to altered
cell characteristics and might contribute to cell transformation as
occurs, for example, in the MMTV-Gli1 mice (Fiaschi et al., 2009).
However, our data suggest further that, while the mammary
epithelial cells appear refractory to Hh-signalling through the
canonical pathway, non-canonical signalling cascades can be
invoked.
To conclude, combined with our data characterizing the effect
of the MMTV-c-srcAct allele on development in the mes mammary
gland, our data suggest that a novel Hh-signalling pathway
involving the activities of ERα and c-src are required for mammary
gland morphogenesis at puberty. These data suggest further that,
for mammary epithelial cells, non-canonical pathways rather
than the canonical Hh-pathway operating through smo are
required for branching morphogenesis at this stage of mammary
gland development.
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